Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The combination of systemic inflammation-based marker NLR and circulating regulatory T cells predicts the prognosis of resectable pancreatic cancer patients
Cheng He, Guopei Luo, Lu Yu, et al.
Pancreatology (2016) Vol. 16, Iss. 6, pp. 1080-1084
Closed Access | Times Cited: 60

Showing 26-50 of 60 citing articles:

Pretherapy neutrophil to lymphocyte ratio and platelet to lymphocyte ratio do not predict survival in resectable pancreatic cancer
Akhil Chawla, Tiffany L. Huang, Andrew Ibrahim, et al.
HPB (2017) Vol. 20, Iss. 5, pp. 398-404
Open Access | Times Cited: 28
Significance of Combined Preoperative Serum ALB and DNLR For Diagnosis of Pancreatic Cancer
Jiaxin Liu, Ang Li, Linying Zhou, et al.
Future Oncology (2018) Vol. 14, Iss. 3, pp. 229-239
Closed Access | Times Cited: 27
The Peripheral and Intratumoral Immune Cell Landscape in Cancer Patients: A Proxy for Tumor Biology and a Tool for Outcome Prediction
Annette Schnell, Christian Schmidl, Wolfgang Herr, et al.
Biomedicines (2018) Vol. 6, Iss. 1, pp. 25-25
Open Access | Times Cited: 26
CA19.9 Serum Level Predicts Lymph-Nodes Status in Resectable Pancreatic Ductal Adenocarcinoma: A Retrospective Single-Center Analysis
Alessandro Coppola, Vincenzo La Vaccara, Michele Fiore, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 20
PD-L1+NEUT, Foxp3+Treg, and NLR as New Prognostic Marker with Low Survival Benefits Value in Hepatocellular Carcinoma
Lin Zhou, Jing Wang, Shaocheng Lyu, et al.
Technology in Cancer Research & Treatment (2021) Vol. 20
Open Access | Times Cited: 18
Baseline immunity predicts prognosis of pancreatic cancer patients treated with WT1 and/or MUC1 peptide-loaded dendritic cell vaccination and a standard chemotherapy
Shuichi Ota, Mamiko Miyashita, Yuka Yamagishi, et al.
Human Vaccines & Immunotherapeutics (2021) Vol. 17, Iss. 12, pp. 5563-5572
Open Access | Times Cited: 18
Neutrophil-to-lymphocyte ratio predicts survival of patients with rectal cancer receiving neo-adjuvant chemoradiation followed by radical resection: a meta-analysis
Giuseppe A. Colloca, Antonella Venturino, Domenico Guarneri
Expert Review of Anticancer Therapy (2023) Vol. 23, Iss. 4, pp. 421-429
Closed Access | Times Cited: 7
Polymorphisms within autophagy‐related genes as susceptibility biomarkers for pancreatic cancer: A meta‐analysis of three large European cohorts and functional characterization
Fernando Gálvez, Giulia Peduzzi, José Manuel Sánchez‐Maldonado, et al.
International Journal of Cancer (2024) Vol. 156, Iss. 2, pp. 339-352
Open Access | Times Cited: 2
The efficacy of immune checkpoint inhibitors in advanced hepatocellular carcinoma: a meta-analysis based on 40 cohorts incorporating 3697 individuals
Rixiong Wang, Nan Lin, Binbin Mao, et al.
Journal of Cancer Research and Clinical Oncology (2021) Vol. 148, Iss. 5, pp. 1195-1210
Closed Access | Times Cited: 16
The CANLPH Score, an Integrative Model of Systemic Inflammation and Nutrition Status (SINS), Predicts Clinical Outcomes After Surgery in Renal Cell Carcinoma: Data From a Multicenter Cohort in Japan
Kazumasa Komura, Takeshi Hashimoto, Takuya Tsujino, et al.
Annals of Surgical Oncology (2019) Vol. 26, Iss. 9, pp. 2994-3004
Closed Access | Times Cited: 17
Prognostic Significance of Neutrophil-to-Lymphocyte Ratio in Differentiated Thyroid Carcinoma Having Distant Metastasis: A Comparison With Thyroglobulin-doubling Rate and Tumor Volume-doubling Rate
Yasuhiro Ito, Naoyoshi Onoda, Minoru Kihara, et al.
In Vivo (2021) Vol. 35, Iss. 2, pp. 1125-1132
Open Access | Times Cited: 14
Risk factors and prognostic index model for pancreatic cancer
Hui Huang, Jichun Sun, Zheming Jiang, et al.
Gland Surgery (2022) Vol. 11, Iss. 1, pp. 186-195
Open Access | Times Cited: 9
The Prognostic Value of Preoperative Neutrophil‐to‐Lymphocyte Ratio in Resected Patients with Pancreatic Adenocarcinoma
Le‐ping Fang, Xiaoyan Xu, Yu Ji, et al.
World Journal of Surgery (2018) Vol. 42, Iss. 11, pp. 3736-3745
Closed Access | Times Cited: 13
Utility of preoperative systemic inflammatory biomarkers in predicting postoperative complications after pancreaticoduodenectomy: Literature review and single center experience
Alessandro Coppola, Vincenzo La Vaccara, Lorenza Caggiati, et al.
World Journal of Gastrointestinal Surgery (2021) Vol. 13, Iss. 10, pp. 1216-1225
Open Access | Times Cited: 11
Microsatellite Instability Correlated Inflammatory Markers and their Prognostic Value in the Rectal Cancer Following Neoadjuvant Chemoradiotherapy: A Hypothesis-generating Study
Joo Ho Lee, Byung Hee Kang, Changhoon Song, et al.
In Vivo (2020) Vol. 34, Iss. 4, pp. 2119-2126
Open Access | Times Cited: 10
<p>Definitive chemoradiotherapy and salvage chemotherapy for patients with isolated locoregional recurrence after radical resection of primary pancreatic cancer</p>
Wei Shi, Rui Jiang, Fei Liang, et al.
Cancer Management and Research (2019) Vol. Volume 11, pp. 5065-5073
Open Access | Times Cited: 9
Pancreatic Tumor Microenvironment
Kai Wang, Hong He
Advances in experimental medicine and biology (2020), pp. 243-257
Closed Access | Times Cited: 9
Immunomodulatory Effects of Endoscopic Ultrasound-Guided Thermal Ablation in Patients with Pancreatic Ductal Adenocarcinoma
Sabrina Gloria Giulia Testoni, Claudia Minici, Elisa Benetti, et al.
Cancers (2023) Vol. 15, Iss. 14, pp. 3704-3704
Open Access | Times Cited: 3
Novel insight into pancreatic adenocarcinoma pathogenesis using liquid association analysis
Zahra Shokati Eshkiki, Nasibeh Khayer, Atefeh Talebi, et al.
BMC Medical Genomics (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 5
Advance of T regulatory cells in tumor microenvironment remodeling and immunotherapy in pancreatic cancer
Zetian Gao, Qiubo Zhang, Xie Zhang, et al.
European Journal of Inflammation (2022) Vol. 20
Open Access | Times Cited: 5
Preoperative systemic inflammatory biomarkers and postoperative day 1 drain amylase value predict grade C pancreatic fistula after pancreaticoduodenectomy
Damiano Caputo, Alessandro Coppola, Chiara Cascone, et al.
Annals of Medicine and Surgery (2020) Vol. 57, pp. 56-61
Open Access | Times Cited: 6
Clinical significance of peripheral blood-derived inflammation markers combined with serum eotaxin-2 in human colorectal cancer
Mingfu Tong, Huimin Liu, Huan Xu, et al.
Biotechnology and Genetic Engineering Reviews (2023) Vol. 40, Iss. 3, pp. 1774-1790
Closed Access | Times Cited: 2
Pretreatment platelet to lymphocyte ratio is predictive of overall survival in metastatic pancreatic ductal adenocarcinoma
Wanwan Li, Chen Yang, Xuelin Wang, et al.
Translational Cancer Research (2019) Vol. 8, Iss. 1, pp. 17-22
Open Access | Times Cited: 5
Serum microRNAs as new criteria for referral to early palliative care services in treatment-naïve advanced cancer patients
Tomofumi Miura, Shuichi Mitsunaga, Juntaro Matsuzaki, et al.
Oncotarget (2022) Vol. 13, Iss. 1, pp. 1341-1349
Open Access | Times Cited: 3
Systemic Inflammatory Response in Pancreatic Ductal Adenocarcinoma
Arturs Silovs, Ilze Štrumfa, R. Riekstinš, et al.
InTech eBooks (2018)
Open Access | Times Cited: 3

Scroll to top